Performance and egg quality of laying hens fed diets containing aflatoxin, fumonisin and adsorbent

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Effects of prolonged oral administration of fumonisin B(1) and aflatoxin B(1) in rats

The effects of prolonged oral administration (21 days) of fumonisin B(1) (FB(1)) and aflatoxin B(1) (AFB(1)) were evaluated on male Wistar rats. The animals were housed in individual metabolic cages and submitted to the following treatments: 1-0 mug AFB(1) + 0 mg FB(1)/100g bw.; 2-72 mug AFB(1)+ 0 mg FB(1)/100 g bw; 3-0 mug AFB(1) + 0.5 mg FB(1) g bw; 4-0 mug AFB(1) + 1.5 mg FB(1)/100 g bw; 5-72 mug AFB(1) + 0.5 mg FB(1)/100g bw; 6-72 mu gAFB(1) + 1.5 mg FB(1)/100g bw. on day 21, the rats were sacrificed for evaluation. The results showed that treated animals presented differences in body weight and absolute/relative weights of liver and kidney as well as altered hepatic function and cholesterol blood levels. Rats fed with the greatest doses of AFB(1) and FB(1) gained less weight (2.79 g/day) at the end of the experimental period; their blood concentrations of liver enzymes aspartate aminotransferase (AST) and alkaline phosphatase (AP) were above control levels (130.35 mu /l and 471.00 mu /l, respectively). Blood cholesterol increased in the groups treated with the highest dose of FB(1) or FB(1) associated with AFB(1). Histopathology revealed the occurrence of apoptosis in the liver of rats exposed to FB(1). The association of aflatoxin B(1) with fumonisin B(1) at higher dose probably potentiated the effects of the higher dose of fumonisin B(1)acting singly.

Lipid metabolism of commercial layers fed diets containing aflatoxin, fumonisin, and a binder

Aflatoxins (AF) and fumonisins (FU) are a major problem faced by poultry farmers, leading to huge economic losses. This experiment was conducted to determine the effects of AF (1 mg/kg of feed) and FU (25 mg/kg of feed), singly or in combination, on the lipid metabolism in commercial layers and investigate the efficacy of a commercial binder (2 kg/t of feed) on reducing the toxic effects of these mycotoxins. A total of 168 Hisex Brown layer hens, 37 wk of age, were randomized into a 3 × 2 + 1 factorial arrangement (3 diets with no binder containing AF, FU, and AF+FU; 3 diets with binder containing AF, FU, and AF+FU; and a control diet with no mycotoxins and binders), totaling 7 treatments. The hens contaminated with AF showed the characteristic effects of aflatoxicosis, such as a yellow liver, resulting from the accumulation of liver fat, lower values of plasma very low-density lipoprotein and triglycerides, and higher relative weight of the kidneys and liver. Hepatotoxic and nephrotoxic effects of FU were not observed in this study. On the other hand, the FU caused a reduction in small intestine length and an increase in abdominal fat deposition. The glucan-based binder prevented some of the deleterious effects of these mycotoxins, particularly the effects of AF on hepatic lipid metabolism, kidney relative weight, and FU in the small intestine. © 2013 Poultry Science Association Inc.

Optimisation of a sample preparation method for the determination of fumonisin B-1 in rice

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Fumonisina B1 em arroz: desenvolvimento de método analítico, validação e ocorrência

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Desempenho, qualidade de ovos e metabolismo lipídico de poedeiras comerciais alimentadas com dietas contendo aflatoxina, fumonisina e adsorvente

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Adsorvente de micotoxinas em dietas de frangos de corte contendo aflatoxina e fumonisina

Pós-graduação em Ciência e Tecnologia Animal - FEIS

Determinação de fumosina B1, por CLAE: estudo da estabilidade do derivado fumonisina B1-orto-ftaldialdeído

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Determinação de fumonisina B1 por CLAE: estudo da estabilidade do derivado fumonisina B1-orto-ftaldialdeído

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)